IGFL2 and cancer: Then we analyzed the samples of KIRC, KIRP, and KICH simultaneously to obtain the results of mixed renal carcinoma, which showed that IGFL2 expression was significantly higher in the advanced stage of cancer than in the early clinical stage, and was a risk factor affecting prognosis.